Progesterone Receptor Negative Active Not Recruiting Phase 3 Trials for Paclitaxel (DB01229)

DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting3 IdentifierTitlePurposeDrugs
NCT00785291Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerTreatment
NCT01275677Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerTreatment